X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tumors (6) 6
cancer (5) 5
chemotherapy (5) 5
thromboembolism (5) 5
cisplatin (4) 4
humans (4) 4
index medicus (4) 4
female (3) 3
middle aged (3) 3
oncology (3) 3
patients (3) 3
risk factors (3) 3
studies (3) 3
thrombosis (3) 3
adult (2) 2
anticoagulants (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
biomarkers (2) 2
epidemiology (2) 2
hematology, oncology and palliative medicine (2) 2
heparin (2) 2
l-lactate dehydrogenase (2) 2
lactate dehydrogenase (2) 2
lactic acid (2) 2
male (2) 2
medical research (2) 2
medicine, experimental (2) 2
prevention (2) 2
prophylaxis (2) 2
research (2) 2
risk analysis (2) 2
surface area (2) 2
[ stat ] statistics [stat] (1) 1
[ stat.ap ] statistics [stat]/applications [stat.ap] (1) 1
[ stat.me ] statistics [stat]/methodology [stat.me] (1) 1
[ stat.ml ] statistics [stat]/machine learning [stat.ml] (1) 1
[ stat.ot ] statistics [stat]/other statistics [stat.ml] (1) 1
[stat.ap]statistics [stat]/applications [stat.ap] (1) 1
[stat.me]statistics [stat]/methodology [stat.me] (1) 1
[stat.ml]statistics [stat]/machine learning [stat.ml] (1) 1
[stat.ot]statistics [stat]/other statistics [stat.ml] (1) 1
[stat]statistics [stat] (1) 1
adolescent (1) 1
aged (1) 1
algorithms (1) 1
amplification (1) 1
analysis (1) 1
anorexia (1) 1
anticancer properties (1) 1
anticoagulants - therapeutic use (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antitumor activity (1) 1
applications (1) 1
asthenia (1) 1
ataxia (1) 1
biological effects (1) 1
biological products - adverse effects (1) 1
biological products - pharmacokinetics (1) 1
biological products - therapeutic use (1) 1
biopsy (1) 1
biopsy, fine-needle (1) 1
biopsy, large-core needle (1) 1
body surface area (1) 1
bortezomib (1) 1
bortezomib - adverse effects (1) 1
bortezomib - pharmacokinetics (1) 1
bortezomib - therapeutic use (1) 1
bortezomib daily dose (1) 1
breast - pathology (1) 1
breast cancer (1) 1
breast carcinoma (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - immunology (1) 1
breast neoplasms - pathology (1) 1
breast neoplasms - surgery (1) 1
cancer patients (1) 1
cancer therapies (1) 1
carboplatin (1) 1
carcinomas (1) 1
cellular biology (1) 1
chemoprevention (1) 1
cisplatin - therapeutic use (1) 1
classification (1) 1
classification tree algorithm (1) 1
cohort (1) 1
comparative analysis (1) 1
computer simulation (1) 1
cytology (1) 1
dehydrogenases (1) 1
deoxyribonucleic acid--dna (1) 1
discriminant analysis (1) 1
dosage and administration (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
economic theory/quantitative economics/mathematical methods (1) 1
erbb-2 protein (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Pathology, ISSN 0893-3952, 10/2016, Volume 29, Issue 10, pp. 1155 - 1164
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2018, Volume 36, Issue 4, pp. 619 - 628
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 04/2017, Volume 75, p. 333
The authors regret that the name of the co-author Gwenael Le Teuff was incorrect in the original version. It has now been corrected as above. The authors would... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 151
Abstract Background: Patients with germ cell tumours (GCT) receiving cisplatin-based chemotherapy are at high risk of thromboembolic events (TEE). Previously,... 
Anticoagulants | Medical treatment | Prophylaxis | Lactate dehydrogenase | Thrombophlebitis | Risk analysis | Patients | Thrombosis | Cisplatin | L-Lactate dehydrogenase | Molecular chains | Risk factors | Studies | Chemotherapy | Lactic acid | Heparin | Thromboembolism | Surface area | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 151
Background: Patients with germ cell tumours (GCT) receiving cisplatin-based chemotherapy are at high risk of thromboembolic events (TEE). Previously, we... 
Anticoagulants | Dehydrogenases | Prophylaxis | Lactate dehydrogenase | Risk analysis | Thrombosis | Patients | Cisplatin | L-Lactate dehydrogenase | Risk factors | Chemotherapy | Platinum | Lactic acid | Heparin | Thromboembolism | Surface area | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 69, pp. 151 - 157
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.